INIS
antibiotics
100%
asia
38%
attitudes
19%
classification
8%
consumption rates
6%
control
7%
covid-19
15%
doses
14%
evaluation
19%
exceptions
6%
hospitals
25%
humans
19%
implementation
6%
kazakhstan
77%
metronidazole
6%
modeling
6%
patients
11%
policy
41%
populations
19%
research programs
9%
surveillance
5%
surveys
21%
time-series analysis
6%
Keyphrases
Antibiotic Stewardship
38%
Antibiotic Use
22%
Antifungal Agents
19%
Antimicrobial Resistance
58%
Antiprotozoal
19%
Antiprotozoal Agents
19%
Central Asia
38%
Collaborative Research
9%
Consumption Trends
19%
COVID-19 Pandemic
7%
Defined Daily Dose
7%
Evidence-based Policy
38%
Evidence-based Practice
38%
Kazakhstan
38%
Knowledge Attitude
19%
Knowledge Practices
19%
Law Enforcement
7%
Point Prevalence Survey
19%
Systemic Antibiotics
7%
Systemic Antifungals
6%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Agent
19%
Antibiotics
19%
Antifungal Agent
19%
Antimicrobial Resistance
19%
Antiprotozoal Agent
19%
Defined Daily Dose
5%
Pandemic
8%